Article info

Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice

Authors

  1. Correspondence to Professor Marjolijn J L Ligtenberg, Pathology, Radboudumc, Nijmegen 6500 HB, The Netherlands; Marjolijn.Ligtenberg{at}radboudumc.nl
View Full Text

Citation

Steeghs EMP, Vink GR, Elferink MAG, et al
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice

Publication history

  • Received August 2, 2021
  • Accepted October 4, 2021
  • First published October 21, 2021.
Online issue publication 
September 19, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.